764 related articles for article (PubMed ID: 24669978)
21. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
Samy AM; Marzouk MA; Ammar AA; Ahmed MK
Drug Discov Ther; 2010 Apr; 4(2):77-84. PubMed ID: 22491164
[TBL] [Abstract][Full Text] [Related]
23. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
[TBL] [Abstract][Full Text] [Related]
24. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir.
Sinha S; Ali M; Baboota S; Ahuja A; Kumar A; Ali J
AAPS PharmSciTech; 2010 Jun; 11(2):518-27. PubMed ID: 20238187
[TBL] [Abstract][Full Text] [Related]
25. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
Zhao X; Liu X; Gan L; Zhou C; Mo J
Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
[TBL] [Abstract][Full Text] [Related]
26. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
27. Development of solid dispersion systems of dapivirine to enhance its solubility.
Gorajana A; Ying CC; Shuang Y; Fong P; Tan Z; Gupta J; Talekar M; Sharma M; Garg S
Curr Drug Deliv; 2013 Jun; 10(3):309-16. PubMed ID: 23360246
[TBL] [Abstract][Full Text] [Related]
28. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
29. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
30. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
Leonardi D; Barrera MG; Lamas MC; Salomón CJ
AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
[TBL] [Abstract][Full Text] [Related]
31. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
[TBL] [Abstract][Full Text] [Related]
32. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
Chella N; Tadikonda R
Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
[TBL] [Abstract][Full Text] [Related]
33. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
34. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
35. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
[TBL] [Abstract][Full Text] [Related]
36. Study of the physicochemical properties and oral bioavailability of the solid dispersion of cantharidin with polyethylene glycol 4000.
Dang YJ; Hu CH; An LN; Zhu CY
Methods Find Exp Clin Pharmacol; 2010 Apr; 32(3):157-62. PubMed ID: 20448857
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of dissolution profile by solid dispersion (kneading) technique.
Modi A; Tayade P
AAPS PharmSciTech; 2006 Aug; 7(3):68. PubMed ID: 17025249
[TBL] [Abstract][Full Text] [Related]
38. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.
Eedara BB; Veerareddy PR; Jukanti R; Bandari S
Drug Dev Ind Pharm; 2014 Aug; 40(8):1030-43. PubMed ID: 23738504
[TBL] [Abstract][Full Text] [Related]
39. Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.
Chella N; Daravath B; Kumar D; Tadikonda RR
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):517-26. PubMed ID: 26156887
[TBL] [Abstract][Full Text] [Related]
40. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
Potluri RH; Bandari S; Jukanti R; Veerareddy PR
Arch Pharm Res; 2011 Jan; 34(1):51-7. PubMed ID: 21468915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]